188 related articles for article (PubMed ID: 21856863)
1. Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.
Barrett DM; Seif AE; Carpenito C; Teachey DT; Fish JD; June CH; Grupp SA; Reid GS
Blood; 2011 Oct; 118(15):e112-7. PubMed ID: 21856863
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a bioluminescent imaging-based in vivo leukemia model by intra-bone marrow injection.
Lee MW; Kim HJ; Yoo KH; Kim DS; Yang JM; Kim HR; Noh YH; Baek H; Kwon H; Son MH; Lee SH; Cheuh HW; Jung HL; Sung KW; Koo HH
Int J Oncol; 2012 Dec; 41(6):2047-56. PubMed ID: 23007607
[TBL] [Abstract][Full Text] [Related]
3. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.
Terziyska N; Castro Alves C; Groiss V; Schneider K; Farkasova K; Ogris M; Wagner E; Ehrhardt H; Brentjens RJ; zur Stadt U; Horstmann M; Quintanilla-Martinez L; Jeremias I
PLoS One; 2012; 7(12):e52798. PubMed ID: 23300782
[TBL] [Abstract][Full Text] [Related]
5. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
[TBL] [Abstract][Full Text] [Related]
7. Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2012 Dec; 41(6):2207-12. PubMed ID: 23041950
[TBL] [Abstract][Full Text] [Related]
8. A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl.
Mishra S; Zhang B; Groffen J; Heisterkamp N
Leukemia; 2004 Jan; 18(1):23-8. PubMed ID: 14603339
[TBL] [Abstract][Full Text] [Related]
9. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.
Morisot S; Wayne AS; Bohana-Kashtan O; Kaplan IM; Gocke CD; Hildreth R; Stetler-Stevenson M; Walker RL; Davis S; Meltzer PS; Wheelan SJ; Brown P; Jones RJ; Shultz LD; Civin CI
Leukemia; 2010 Nov; 24(11):1859-66. PubMed ID: 20739953
[TBL] [Abstract][Full Text] [Related]
10. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies.
Liem NL; Papa RA; Milross CG; Schmid MA; Tajbakhsh M; Choi S; Ramirez CD; Rice AM; Haber M; Norris MD; MacKenzie KL; Lock RB
Blood; 2004 May; 103(10):3905-14. PubMed ID: 14764536
[TBL] [Abstract][Full Text] [Related]
11. Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
Milani M; Laranjeira AB; de Vasconcellos JF; Brandalise SR; Nowill AE; Yunes JA
PLoS One; 2015; 10(6):e0129298. PubMed ID: 26068922
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Einsiedel HG; Kawan L; Eckert C; Witt O; Fichtner I; Henze G; Seeger K
Leukemia; 2006 Aug; 20(8):1435-6. PubMed ID: 16810202
[No Abstract] [Full Text] [Related]
13. Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles.
Fazzina R; Lombardini L; Mezzanotte L; Roda A; Hrelia P; Pession A; Tonelli R
Int J Oncol; 2012 Aug; 41(2):621-8. PubMed ID: 22665135
[TBL] [Abstract][Full Text] [Related]
14. Preclinical testing of antileukemic drugs using an in vivo model of systemic disease.
Lock RB; Liem NL; Papa RA
Methods Mol Med; 2005; 111():323-34. PubMed ID: 15911988
[TBL] [Abstract][Full Text] [Related]
15. Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculation.
Wang N; Huang L; Wang D; Wang J; Jiang L; Zhou K; Yang Y; Xu D; Zhou J
Cancer Biol Ther; 2012 Oct; 13(12):1158-64. PubMed ID: 22892848
[TBL] [Abstract][Full Text] [Related]
16. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
17. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
Cheung AM; Fung TK; Fan AK; Wan TS; Chow HC; Leung JC; Chan LY; Kwong YL; Liang R; Leung AY
Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
[TBL] [Abstract][Full Text] [Related]
18. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
19. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
[No Abstract] [Full Text] [Related]
20. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
